Tag: OpGen Inc (NASDAQ: OPGN)


OpGen Inc (NASDAQ: OPGN) Achieve Milestone in Unyvero A30 RQ Platform Program

OpGen Inc (NASDAQ: OPGN) is a precision medicine company attaching the power of molecular diagnostics and bioinformatics to contain infectious diseases. The company announced that its subsidiary Curetis GmbH and its engineering partner had assembled 10 final pre-series release analyzer instruments of the Unyvero A30 RQ platform. The completion of […]